Drugs that are used to treat Covid or used by people as immunity boosters have seen a jump in sales and, in turn, rankings, reports Sohini Das. IMAGE: A chemist displays the Fabiflu......
Drug firm Glenmark Pharmaceuticals on Saturday said it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19 at a price......
The Gautam Gambhir Foundation has been found guilty of unauthorisedly stocking, procuring and distributing Fabiflu medicine to COVID-19 patients, the Delhi high court was informed by the Delhi......
Delhi's drugs control department has told the Delhi high court that it has launched prosecution against Gautam Gambhir Foundation and Aam Aadmi Party MLAs, Imran Hussain and Praveen Kumar, before a......
Yoga guru Ramdev on Wednesday approached the Supreme Court seeking a stay on the proceedings in multiple cases lodged against him in various states over his alleged remarks on the efficacy of......
The Drug Controller General of India has sent a letter to the Glenmark seeking clarifications on pricing as well as claims of therapeutic efficacy. While Glenmark has claimed this drug is effective......
Fabiflu sales have grown by 62 per cent in July. It was launched in June. This drug is being used by doctors for mild-to-moderate Covid patients even if they are in home isolation. Even as the......
Favipiravir is the only oral anti-viral treatment approved in India for potential treatment of patients with mild to moderate Covid-19 disease. Joining the long list of firms to launch its own......
From July 10, when it was launched till August 7, 1,087,030 lives have been covered under Corona Kavach through 648,276 policies with premium of Rs 182 crore and sum assured for Rs 42,956 crore.......